NO912341L - PROCEDURE FOR THE PREPARATION OF HIV REVERS TRANSCIPTASE INHIBITORS. - Google Patents
PROCEDURE FOR THE PREPARATION OF HIV REVERS TRANSCIPTASE INHIBITORS.Info
- Publication number
- NO912341L NO912341L NO91912341A NO912341A NO912341L NO 912341 L NO912341 L NO 912341L NO 91912341 A NO91912341 A NO 91912341A NO 912341 A NO912341 A NO 912341A NO 912341 L NO912341 L NO 912341L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- revers
- hiv
- procedure
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Nye forbindelser av formlene. hvori A erellerB er C.-alkoksy; X er NH, 0, S eller CH; Z er 0 eller S; n er 1-4; Rj er (i) C-alkyl, eventuelt substituert med én eller to av C^-alkoksy, halogen, C^-alkylamino, C.-dialkylamino eller C-alkyltio; (ii) C.-lkyltio; (iii) C.-alkoksy; eller (iv) halogen; Rer (i) H; (ii) C-alkyl, eventuelt substituert med én eller to av metoksy, metylamino, dimetylamino eller metyl-tio; Rer H eller C.g-alkyl; Ph er ftaloyl av strukturen. hvori m er 0-2, forutsatt at når A er NH-CH-Ph, kan både Rj og Rikke være C.-alkyl, utviser terapeutisk akti-vitet. Fremstilling av forbindelsene er beskrevet.New compounds of the formulas. wherein A is or B is C 1-4 alkoxy; X is NH, O, S or CH; Z is 0 or S; n is 1-4; R 1 is (i) C 1-4 alkyl, optionally substituted with one or two of C 1-4 alkoxy, halogen, C 1-4 alkylamino, C 1-6 dialkylamino or C 1-4 alkylthio; (ii) C 1-4 alkylthio; (iii) C 1-4 alkoxy; or (iv) halogen; Rer (i) H; (ii) C-alkyl, optionally substituted with one or two of methoxy, methylamino, dimethylamino or methylthio; R 1 is H or C 1-6 alkyl; Ph is phthaloyl of the structure. wherein m is 0-2, provided that when A is NH-CH-Ph, both R j and Rikke may be C 1-6 alkyl, exhibiting therapeutic activity. Preparation of the compounds is described.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53976090A | 1990-06-18 | 1990-06-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO912341D0 NO912341D0 (en) | 1991-06-17 |
NO912341L true NO912341L (en) | 1991-12-19 |
Family
ID=24152525
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO91912341A NO912341L (en) | 1990-06-18 | 1991-06-17 | PROCEDURE FOR THE PREPARATION OF HIV REVERS TRANSCIPTASE INHIBITORS. |
Country Status (3)
Country | Link |
---|---|
KR (1) | KR920000747A (en) |
NO (1) | NO912341L (en) |
ZA (1) | ZA914653B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030010452A (en) * | 2001-11-30 | 2003-02-05 | 이종선 | Automatic Modular Cleaner System |
-
1991
- 1991-06-17 KR KR1019910010056A patent/KR920000747A/en not_active Application Discontinuation
- 1991-06-17 NO NO91912341A patent/NO912341L/en unknown
- 1991-06-18 ZA ZA914653A patent/ZA914653B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA914653B (en) | 1992-03-25 |
KR920000747A (en) | 1992-01-29 |
NO912341D0 (en) | 1991-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL292101A1 (en) | Method of obtaining novel derivatives of cyclopentylpurine and cyclopentylpyrimidine | |
NO163819C (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1H-IMIDAZO (4,5-C) QUINOLINE AND DERIVATIVES THEREOF. | |
ES8707223A1 (en) | Benzothiazole and benzothiophene derivatives. | |
NO892851L (en) | PREPARATION AND USE OF QQUINOLINE DERIVATIVES. | |
FI862757A0 (en) | PYRIDONKARBONSYRADERIVAT OCH FOERFARANDE FOER FRAMSTAELLNING AV DESSA. | |
ATE45354T1 (en) | QUINOLONECARBONIC ACID DERIVATIVES. | |
DK12087D0 (en) | DECAHYDROQUINOLINE DERIVATIVES, THEIR PREPARATION AND USE, AND PREPARATIONS WITH CONTENTS | |
IE890177L (en) | Piperidinyl derivatives | |
NO933611L (en) | ANTI-TUMOR AND ANTI-PSORIATIC AGENTS | |
ES8800122A1 (en) | Indene and naphthalene derivatives. | |
NO971142L (en) | Bis- (2-haloethyl) aminophenyl-substituted distamycin derivatives as antitumor and antiviral agents | |
NO912341L (en) | PROCEDURE FOR THE PREPARATION OF HIV REVERS TRANSCIPTASE INHIBITORS. | |
ATE140229T1 (en) | BENZOXAZEPINONE PROCEDURE | |
DE3667790D1 (en) | PYRIDO (1,2-A) PYRIMIDINE DERIVATIVES. | |
DE69023045D1 (en) | Carboxamide derivatives. | |
GB2334032A (en) | Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumour agents | |
DE69826034D1 (en) | 1,2-dihydro-2-oxoquinoline-DERIVATIVES | |
BG60248B1 (en) | METHOD FOR THE PREPARATION OF PHENOXYETHYLAMINE DERIVATIVES | |
ATE94050T1 (en) | MEANS FOR PREVENTING PLAQUE FORMATION. | |
HU912216D0 (en) | Process for the production of purinyl-and pirimidinyl - tetrahydrofurane derivatives and medical preparations containing them | |
DK0784973T3 (en) | Quinoxaline derivatives for the treatment of tinnitus | |
DK283189A (en) | PHENOTHIAZINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS THEREOF | |
DK492687D0 (en) | INDOLQUINOXALINES WITH SUBSTITUTIONS IN 6-STAGE CONTAINING CYCLIC GROUPS | |
FI955680A (en) | Psoralen derivatives, their preparation and use | |
ES2039270T3 (en) | GAMMA-L-GLUTAMIL-4-NITROANILIDE DERIVATIVES AND PROCEDURE FOR DETERMINING GAMMA-GTP ACTIVITY USING THEM. |